C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.
Open Access
- 1 June 1995
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 181 (6) , 2119-2127
- https://doi.org/10.1084/jem.181.6.2119
Abstract
Inflammatory action of the potent chemotaxin C5a has been well characterized on a variety of human cell types, including neutrophils, monocytes, basophils, and eosinophils. The cellular effects of C3a are less well defined. Contradictory reports have been published for C3a activation of neutrophils. Recent reports that C3a activates both basophils and eosinophils prompted us to reinvestigate the effects of C3a stimulation on eosinophils. We hypothesized that C3a activation of eosinophils, cells that are present in most neutrophil preparations, might lead to neutrophil activation. Using neutrophils of 98% purity, we observed no evidence of cellular activation after stimulation with either C3a, recombinant human C3a (rhC3a), or the synthetic C3a analogue C3a 57-77, Y57. Eosinophils purified to > 98% purity displayed concentration-dependent polarization, chemotaxis, and enzyme release by stimulation with C3a, rhC3a, and the synthetic C3a analogue. An inactive form of C3a, C3adesArg, failed to stimulate either eosinophils or neutrophils. Using neutrophil preparations containing 5-9% eosinophils, up to 20% of neutrophils became polarized after exposure to C3a. Likewise, we demonstrated that supernatant from C3a-stimulated eosinophils promotes neutrophil chemotaxis. Eosinophil polarization experiments were repeated in the presence of antibody to the C5a receptor (C5aR) to show that C3a and C5a interact with different receptors. C3a activates eosinophils in the presence of anti-C5aR antibody at concentrations that fully block C5a activation. We conclude that eosinophils are directly activated by either C3a or C5a, whereas C3a failed to activate neutrophils. C3a acts on eosinophils via a receptor that is distinct from C5aR. Since neutrophils are indirectly stimulated by C3a, eosinophils contaminating neutrophil preparations may explain earlier reports that C3a activates human neutrophils.Keywords
This publication has 51 references indexed in Scilit:
- Evaluation of the C‐terminal C5a effector site with short synthetic C5a analog peptidesEuropean Journal of Immunology, 1993
- Eosinophil Migration in Atopic Dermatitis I: Increased Migratory Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine, Neutrophil-Activating Factor, Platelet-Activating Factor, and Platelet Factor 4Journal of Investigative Dermatology, 1993
- Active recombinant C3a of human anaphylatoxin produced in Escherichia coliBiochemical and Biophysical Research Communications, 1991
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Studies on C3ahu Binding to Human Eosinophils: Characterization of BindingInternational Archives of Allergy and Immunology, 1984
- Purification of horse eosinophil peroxidaseBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- Morphological Changes in Human Polymorphonuclear Leukocytes Induced by C3a in the Presence and Absence of Cytochalasin BInternational Archives of Allergy and Immunology, 1982
- Effects of Corticosteroids on Eosinophil Chemotaxis and AdherenceJournal of Clinical Investigation, 1981
- Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.Journal of Clinical Investigation, 1974
- Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidaseJournal of Clinical Investigation, 1970